Antoine Pariente

Common variants in glucuronidation enzymes and membrane transporters as potential risk factors for colorectal cancer: a case control study

A. Pariente, P. Marquet, R. Guimbaud, 2017, BMC Cancer.

When Patients Report Diseases That Prescribers Seem Unaware of: Discordance Between Patient and Physician Reporting of Risk‐Related Previous History in NSAID Users From the CADEUS Study

A. Pariente, A. Fourrier-Réglat, R. Lassalle, 2010, Clinical pharmacology and therapeutics.

Cardiovascular and Gastrointestinal Safety of NSAIDs: A Systematic Review of Meta‐Analyses of Randomized Clinical Trials

A. Pariente, A. Fourrier-Réglat, M. Sturkenboom, 2011, Clinical pharmacology and therapeutics.

Insulin glargine and risk of cancer: a cohort study in the French National Healthcare Insurance Database

A. Pariente, H. Gin, N. Moore, 2012, Diabetologia.

Statin treatment is not associated with an increased risk of adrenal insufficiency in real-world setting

J. Bezin, S. Maumus-Robert, Antoine Pariente, 2023, Frontiers in Endocrinology.

Sudden cardiac and sudden unexpected death related to antipsychotics: A meta‐analysis of observational studies

A. Fourrier-Réglat, E. Raschi, P. Robinson, 2016, Clinical pharmacology and therapeutics.

Trajectories of Benzodiazepine Use among Older Adults from a Concordance-with-Guidelines Perspective: A Nationwide Cohort Study

B. Bégaud, M. Tournier, S. Maumus-Robert, 2023, Drugs & Aging.

Pharmacovigilance of sodium-glucose co-transporter-2 inhibitors: What a clinician should know on disproportionality analysis of spontaneous reporting systems.

A. Pariente, U. Moretti, E. Poluzzi, 2018, Nutrition, metabolism, and cardiovascular diseases : NMCD.

Use of the recommended drug combination for secondary prevention after a first occurrence of acute coronary syndrome in France

A. Pariente, A. Fourrier-Réglat, N. Moore, 2014, European Journal of Clinical Pharmacology.